Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Actinogen Medical

News headline image
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
News headline image
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
News headline image
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.